Feasibility, safety, and efficacy of robotic single-port hysterectomy (R-SPH) using the da Vinci SP system in low-risk endometrial cancer: a pilot study

• Published in: Minimally invasive therapy and allied technologies p. 1
• Main Authors: Vizza, Riccardo, Corrado, Giacomo, Mancini, Emanuela, Baiocco, Ermelinda, Russo, Mario, Vincenzoni, Cristina, Bruno, Valentina, Falconer, Henrik, Vizza, Enrico
• Format: Journal Article
• Language: English
• Published: England 11.08.2025
• Subjects: endometrial cancer; Da Vinci SP; robotic surgery
• ISSN: 1365-2931
• DOI: 10.1080/13645706.2025.2538764

The purpose of this study was to evaluate the feasibility, safety, and efficacy of robotic single-port hysterectomy (R-SPH) with the da Vinci SP in low-risk endometrial cancer. Patients with clinically confirmed endometrioid endometrial cancer, FIGO stages IA-IB, were enrolled for R-SPH. All surgical procedures were performed through a single 2.5 cm umbilical incision. An Intuitive Access Port of small size was placed into the incision, and pneumoperitoneum was established. Robotic instruments were inserted as described below through the Intuitive Access Port, which has four different channel ports: in the superior channel, a three-dimensional 8.5 mm optics; in channel 1, Cadiere Forceps; in channel 2, a Maryland Bipolar; and in channel 3, monopolar scissors. From June 24 to November 13, 2024, a total of 25 patients were included in the study. The median age was 61 years, and median BMI was 25.9 kg/m . The median docking time, console time, and total operative time were 10, 65, and 115 min, respectively. The median blood loss was 67.0 mL, and the median hemoglobin drop was 1.2 g/dL. R-SPH seems safe and feasible in endometrial cancer. The true benefit of the technique should be sought in larger comparative studies. ClinicalTrials.gov Protocol Record: NCT06681831.